Sio Capital Management, LLC Albireo Pharma, Inc. Transaction History

Sio Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$18.54 - $37.29 $1.59 Million - $3.21 Million	-85,990 Reduced 59.49%	58,556 $1.16 Million
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $1.66 Million - $2.34 Million	-69,367 Reduced 32.43%	144,546 $4.31 Million
Q4 2021 Feb 14, 2022	BUY	$21.19 - $31.29 $8,899 - $13,141	420 Added 0.2%	213,913 $4.98 Million
Q3 2021 Nov 15, 2021	SELL	$27.36 - $35.98 $1.43 Million - $1.88 Million	-52,123 Reduced 19.62%	213,493 $6.66 Million
Q2 2021 Aug 16, 2021	SELL	$28.9 - $36.87 $78,897 - $100,655	-2,730 Reduced 1.02%	265,616 $9.34 Million

Q1 2021 May 14, 2021	SELL	$32.03 - $42.85 $2.75 Million - $3.68 Million	-85,864 Reduced 24.24%	268,346 $9.46 Million
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $3.93 Million - $5.25 Million	-124,414 Reduced 25.99%	354,210 $13.3 Million
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $11.1 Million - $19.9 Million	478,624 New	478,624 $16 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.